Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 3Withdrawn 2Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 6Stomach Neoplasms 3Pain, Postoperative 3Breast Neoplasms 3Neurotoxicity Syndromes 2Neoplasms 2Nasopharyngeal Carcinoma 2Multiple Endocrine Neoplasia Type 1 2Lung Neoplasms 2Delirium 2Colonic Neoplasms 2Warts 1Thoracic Neoplasms 1Spondylitis, Ankylosing 1Spinal Cord Neoplasms 1Skin Diseases 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Pituitary Neoplasms 1Pituitary Diseases 1Peripheral Nervous System Diseases 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms by Site 1Meningioma 1Lymphoma, Follicular 1Low Back Pain 1Fallopian Tube Neoplasms 1

Interventions

Docetaxel 21Radiosurgery 19Radiotherapy 17Androgen Antagonists 14Leuprolide 11Goserelin 11bicalutamide 9enzalutamide 8Surveys and Questionnaires 8Prednisone 8Brachytherapy 8Blood Specimen Collection 8Abiraterone Acetate 8acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 7Radiotherapy, Intensity-Modulated 7Multiparametric Magnetic Resonance Imaging 7Gonadotropin-Releasing Hormone 7Triptorelin Pamoate 6pembrolizumab 4cabazitaxel 4abiraterone 4Standard of Care 4Positron Emission Tomography Computed Tomography 4Metformin 4Heavy Ion Radiotherapy 4Exercise 4Estramustine 4luprolide acetate gel depot 3darolutamide 3Watchful Waiting 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Prostatic Neoplasms × Sodium Chloride × Clear all
NCT05957653 2023-07-24

Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort

RenJi Hospital

Phase 4 Unknown
140 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡